| Literature DB >> 20218908 |
Lucia Stefanini1, Wolfgang Bergmeier.
Abstract
Rapid activation of platelets at sites of vascular injury is a critical event in thrombosis and hemostasis. Here, we review recent findings, which (a) identified CalDAG-GEFI (RasGRP2) at the nexus of the rapid Ca(2+)-dependent platelet activation, (b) demonstrated a complex synergy between signaling provided by CalDAG-GEFI, protein kinase C and the Gi-coupled receptor for ADP, P2Y12, and (c) suggested CalDAG-GEFI as a novel target for anti-platelet therapy.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20218908 PMCID: PMC4119791 DOI: 10.3109/09537101003639931
Source DB: PubMed Journal: Platelets ISSN: 0953-7104 Impact factor: 3.862